Weight-Loss Drug Doesn’t Reduce Risk Of Alzheimer’s – New Studies

Weight-Loss Drug Doesn’t Reduce Risk Of Alzheimer’s – New Studies

The results close the door, for now, on hopes that a treatment for diabetes and obesity might also help protect the brain. The post Weight-Loss Drug Doesn’t Reduce Risk Of Alzheimer’s – New Studies appeared first on Study Finds.

Studies Find One Condition Semaglutide Doesn't Treat: Alzheimer's

Semaglutide, the drug behind the blockbuster weight-loss jabs Ozempic and Wegovy, does not slow cognitive decline in people with early-stage Alzheimer's, according to two large new studies.

'ozempic in a pill' not effective for Alzheimer's disease

Prefer to listen? Check out my podcast here! As blogged previously, there has been interest to investigate whether GLP1-based medications, which are medications originally developed for diabetes and obesity, could benefit Alzheimer’s disease. Some of the thinking here is that GLP1s reduce insulin resistance and related inflammation, and neuroinflammation is part of Alzheimer’s disease. Obesity […]